Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Patent
1985-06-11
1987-05-05
Robinson, Douglas W.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
514234, 514236, 514255, 514267, 544117, 544250, A61K 3155, A61K 31505, C07D21308, C07D21314
Patent
active
046633200
ABSTRACT:
Compounds according to the formula ##STR1## an optical isomer thereof, or a pharmaceutically acceptable acid addition salt thereof wherein:
REFERENCES:
patent: 31617 (1884-06-01), Beverung, Jr. et al.
patent: 3932407 (1976-01-01), Beverung, Jr. et al.
patent: 4070470 (1978-01-01), Nakagawa et al.
patent: 4256748 (1981-03-01), Chodnekar et al.
patent: 4313947 (1982-02-01), Nakagawa et al.
patent: 4596806 (1986-06-01), Ishikawa et al.
European Journal of Medicinal Chemistry, 1982-17, No. 6d, pp. 547-556, by Kienzle et al.
Journal of Pharmacology and Experimental Therapeutics, vol. 211, No. 1 (1979), pp. 26-30 by Hidaka et al.
Alvarez Robert
Bruno John J.
Jones Gordon H.
Pfister Jurg R.
Venuti Michael C.
Krubiner Alan
Moran Tom M.
Robinson Douglas W.
Syntex (U.S.A.) Inc.
Toth Liza K.
LandOfFree
(2-oxo-1,2,3,5-tetrahydroimidazo[2,1-b]quinoazolinyl)oxyalkylami does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with (2-oxo-1,2,3,5-tetrahydroimidazo[2,1-b]quinoazolinyl)oxyalkylami, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and (2-oxo-1,2,3,5-tetrahydroimidazo[2,1-b]quinoazolinyl)oxyalkylami will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2399452